Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
NEPH Nephros Inc
- Stocks
- Healthcare
- NASDAQ: NEPH
Price (delayed)
$4.05
Market cap
$42.93M
P/E Ratio
50.63
Dividend/share
N/A
EPS
$0.08
Enterprise value
$40.18M
Nephros is a leading water technology company in medical and commercial water purification and pathogen detection, headquartered in the USA. Its diverse team of passionate employees are dedicated to advancing
Highlights
The EPS has soared by 157% YoY
Nephros's net income has soared by 156% YoY
Key stats
What are the main financial stats of NEPH
Market
Valuations
Earnings
Shares outstanding
10.6M
Market cap
$42.93M
Enterprise value
$40.18M
Price to earnings (P/E)
50.63
Price to book (P/B)
4.62
Price to sales (P/S)
2.77
EV/EBIT
49.24
EV/EBITDA
41.9
EV/Sales
2.59
Revenue
$15.52M
Gross profit
$9.69M
Operating income
$772,000
Net income
$801,000
EBIT
$816,000
EBITDA
$959,000
Free cash flow
$502,000
Per share
Balance sheet
Liquidity
EPS
$0.08
EPS diluted
$0.08
Free cash flow per share
$0.05
Book value per share
$0.88
Revenue per share
$1.46
TBVPS
$0.99
Total assets
$11.78M
Total liabilities
$2.49M
Debt
$1.33M
Equity
$9.29M
Working capital
$7.47M
Debt to equity
0.14
Current ratio
5.92
Quick ratio
4.45
Net debt/EBITDA
-2.87
Margins
Efficiency
Dividend
EBITDA margin
6.2%
Gross margin
62.4%
Net margin
5.2%
Operating margin
5%
Return on assets
7.2%
Return on equity
9.4%
Return on invested capital
12.8%
Return on capital employed
8%
Return on sales
5.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NEPH stock price
How has the Nephros stock price performed over time
Intraday
6.3%
1 week
23.85%
1 month
113.16%
1 year
84.93%
YTD
175.51%
QTD
135.47%
Financial performance
How have Nephros's revenue and profit performed over time
Revenue
$15.52M
Gross profit
$9.69M
Operating income
$772,000
Net income
$801,000
Gross margin
62.4%
Net margin
5.2%
Nephros's net income has soared by 156% YoY
The company's operating income has surged by 152% YoY
The company's net margin has surged by 151% YoY
The operating margin has soared by 147% YoY
Price vs fundamentals
How does NEPH's price correlate with its fundamentals
Growth
What is Nephros's growth rate over time
Valuation
What is Nephros stock price valuation
P/E
50.63
P/B
4.62
P/S
2.77
EV/EBIT
49.24
EV/EBITDA
41.9
EV/Sales
2.59
The EPS has soared by 157% YoY
NEPH's price to book (P/B) is 98% more than its last 4 quarters average of 2.2 and 9% more than its 5-year quarterly average of 4.0
Nephros's equity has increased by 14% YoY and by 8% QoQ
The price to sales (P/S) is 100% higher than the last 4 quarters average of 1.3 but 33% lower than the 5-year quarterly average of 3.9
The revenue has grown by 10% YoY and by 10% from the previous quarter
Efficiency
How efficient is Nephros business performance
The return on assets has surged by 156% year-on-year
The ROE has soared by 155% YoY
The ROS has soared by 152% YoY
Nephros's ROIC has soared by 145% YoY
Dividends
What is NEPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NEPH.
Financial health
How did Nephros financials performed over time
The company's quick ratio has surged by 67% YoY and by 25% QoQ
The current ratio has increased by 41% YoY and by 11% QoQ
The company's debt is 86% lower than its equity
The debt to equity has declined by 33% year-on-year and by 13% since the previous quarter
The company's debt fell by 22% YoY and by 6% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.